Latest Research Highlights (Canadian & International, 2022–2025) — Start With Evidence, Then Patient Context

Basic Feldene Information

• INN (International Nonproprietary Name): Piroxicam
• Brand Names Available In Canada (English): Feldene; availability depends on manufacturer submissions to Health Canada and DIN listings; check Health Canada product monograph for current status.
• ATC Code: M01AC01
• Forms & Dosages: Capsules 10 mg and 20 mg; tablets 10 mg and 20 mg; dispersible tablets 20 mg; gel/cream 0.5%–1% in some markets.
• Manufacturers In Canada (English): International suppliers include Pfizer, Sandoz, Hexal, Teva, Mylan; local availability depends on distributor/DIN—confirm with wholesalers.
• Registration Status In Canada (English): Prescription-only classification applies internationally; actual registration in Canada depends on a manufacturer filing and DIN issuance—check Health Canada databases for the latest listing.
• OTC / Rx Classification: Prescription-only (Rx) in regulatory jurisdictions reviewed; local pharmacy dispensing and coverage depend on provincial formularies and DIN listings.

Recent systematic reviews from 2022–2025 focusing on oxicam NSAIDs emphasise a pattern: long half-life oxicams are associated with higher gastrointestinal and cardiovascular risk compared with shorter-acting NSAIDs.

Piroxicam’s elimination half-life of approximately 50 hours is a central pharmacokinetic reason clinicians raise safety concerns and recommend the lowest effective dose for the shortest possible time.

Canadian peer-reviewed randomized controlled trials specifically on piroxicam since 2022 are scarce, so Canadian practice leans on international safety data, pharmacovigilance summaries and regulatory advisories.

Observational studies have shown analgesic efficacy for osteoarthritis and rheumatoid arthritis comparable to other NSAIDs but report more persistent adverse events attributable to accumulation from long elimination.

Clinical guidance in many settings now prefers NSAIDs with shorter half-lives or COX-2 selectivity for patients at elevated GI or cardiovascular risk.

Rural Canadian patients may face delayed follow-up when adverse events occur, and bilingual labelling expectations (English/French) can affect comprehension and safe use.

Data Highlight

INN: Piroxicam

ATC: M01AC01

Half-Life: ≈ 50 hours

Clinical Effectiveness In Canada — Health Canada Context, DIN, Provincial Formularies

Patients ask whether piroxicam works as well as other NSAIDs for joint pain.

Clinical effectiveness for osteoarthritis and rheumatoid arthritis in Canada follows international findings: 20 mg once daily provides reliable symptom control for most adults, while some patients achieve relief at 10 mg daily.

Health Canada classifies NSAIDs as prescription medicines and any marketed piroxicam product in Canada should carry a Drug Identification Number (DIN) and an official product monograph.

Clinicians and patients should verify DIN and consult the Health Canada product monograph online before starting therapy.

Check provincial formularies such as Ontario Drug Benefit (ODB), BC PharmaCare and RAMQ for coverage and special-authority conditions, since many formularies favour alternative NSAIDs because of piroxicam’s safety profile.

Baseline renal and liver function tests, blood pressure assessment, and GI-risk evaluation are standard before starting piroxicam.

Review therapy every 2–3 months and consider co-prescribing a proton pump inhibitor for patients at high GI risk.

Major retail chains like Shoppers Drug Mart, Rexall, London Drugs and Jean Coutu dispense prescription medicines nationwide, but actual piroxicam availability varies by supplier and DIN listing.

• DIN — What It Means: A unique identifier assigned by Health Canada to a marketed drug product; use it to confirm formulation and approved indications.
• SmPC — What It Contains: The product monograph (label) outlines indications, dosing, contraindications, adverse effects and monitoring guidance.
• Provincial Formulary — How It Affects Access: Formularies determine public coverage and may require prior authorization for specific patients or indications.

Indications & Expanded Uses — Approved Versus Off‑Label In Canadian Practice

People often want to know what conditions piroxicam is actually approved to treat.

Core indications listed in international product monographs are osteoarthritis and rheumatoid arthritis, with a typical adult dose of 20 mg once daily and a maximum of 20 mg per day.

Some patients do respond adequately at 10 mg once daily and clinicians may trial that lower dose when appropriate.

Off‑label uses encountered in practice—always physician-directed—include short courses for acute gout flares, ankylosing spondylitis, and occasional post‑operative pain.

Off‑label use needs careful risk–benefit discussion because long half‑life increases accumulation and prolongs adverse effects if they occur.

In Canada many rheumatologists and family physicians prefer alternatives for chronic management in older or multimorbid patients.

Piroxicam may be reserved for cases where other NSAIDs are ineffective or not tolerated and where close monitoring is feasible.

• Approved Indications: Osteoarthritis; Rheumatoid arthritis.
• Off‑Label (Use With Caution): Acute gout flares; Ankylosing spondylitis; Short-term post-operative pain (physician-directed).

Use the lowest effective dose for the shortest period and re-evaluate need every 2–3 months.

Provide risk information and written materials in both English and French when possible to support informed consent.

Composition & Brand Landscape — Active Ingredient, Brands, Generics, Packaging

Patients ask whether Feldene is the same as piroxicam found under generic labels.

INN is piroxicam and ATC code is M01AC01.

Internationally piroxicam is available as capsules and tablets in 10 mg and 20 mg strengths, dispersible 20 mg tablets and topical gels or creams at 0.5%–1% in some markets.

Global suppliers include Pfizer, Sandoz, Hexal, Teva and Mylan, with generics from Zentiva, Stada, Egis, Sun Pharma, Medochemie and Krka.

On the Canadian market a manufacturer must submit to Health Canada and obtain a DIN for a product to be listed; pharmacists should confirm DIN and brand availability with wholesalers before dispensing.

Major retail chains may stock different brands and rural pharmacies sometimes rely on centralized wholesalers, which can cause intermittent supply.

• Forms & Dosages Available: Capsules 10 mg and 20 mg; tablets 10 mg and 20 mg; dispersible tablets 20 mg; topical gel/cream 0.5%–1% (market dependent).

Packaging and bilingual labelling vary by manufacturer—ask your pharmacist for the product monograph and request translation assistance if needed.

Contraindications & Special Precautions — Health Canada Advisories And High‑Risk Groups

Who must not take piroxicam?

Absolute contraindications from product monographs include known hypersensitivity to piroxicam or other NSAIDs, active peptic ulcer or GI bleeding, severe heart failure, severe hepatic or renal impairment, post‑CABG use, and pregnancy especially in the third trimester.

Relative contraindications that require close monitoring include mild to moderate kidney or liver dysfunction, uncontrolled hypertension, prior peptic ulcer disease, and concurrent therapy with anticoagulants, antiplatelets or systemic corticosteroids.

In Canada, particular attention should be paid to older adults, Indigenous communities with higher comorbidity burdens, and patients in remote areas where emergency access may be limited.

• Absolute Contraindication: Known NSAID hypersensitivity; active GI bleed; severe cardiac, renal, hepatic failure; recent CABG; pregnancy (third trimester).
• Relative Contraindication: History of ulcers; uncontrolled hypertension; concurrent anticoagulant/antiplatelet therapy; elderly patients—monitor closely.

Pharmacists should flag high‑risk prescriptions in pharmacy management records and document shared decision-making, offering gastroprotection such as a PPI when appropriate.

Culturally safe counselling and engagement with primary care or community health teams can support monitoring in Indigenous and remote communities.

Dosage Guidelines — Standard Canadian Dosing Schedules And Adjustments

How should piroxicam be dosed safely?

Standard adult dosing from international monographs is 20 mg once daily for osteoarthritis and rheumatoid arthritis, with a maximum of 20 mg per day.

Some patients can be started at 10 mg once daily and escalated to 20 mg if required for symptom control.

Elderly patients should start at the lowest effective dose with careful monitoring for GI, renal and cardiovascular events.

Avoid or use caution in renal or hepatic impairment because prolonged elimination increases toxicity risk.

Missed-dose advice: take as soon as remembered unless it’s near the next dose—do not double up.

Overdose signs include nausea, vomiting, GI bleeding, drowsiness and altered consciousness—seek urgent care.

Interactions Overview — Drug, Food And Alcohol Interactions In Canadian Lifestyles

Common interaction questions include combining piroxicam with blood thinners or blood pressure medicines.

Piroxicam increases bleeding risk when taken with anticoagulants and antiplatelet agents (for example warfarin or DOACs and aspirin).

NSAIDs can reduce the antihypertensive effect of ACE inhibitors, ARBs and diuretics and increase nephrotoxicity risk when combined with diuretics or ACE inhibitors.

Concurrent use with corticosteroids or SSRIs increases gastrointestinal bleeding risk, and alcohol further raises that risk and should be minimised.

• High‑Risk Drug Interactions: Anticoagulants/antiplatelets; ACE inhibitors/ARBs with diuretics; systemic corticosteroids; SSRIs.
• Lifestyle Interactions: Alcohol—avoid or minimise; avoid taking additional OTC NSAIDs such as ibuprofen or naproxen without prescriber or pharmacist clearance.

Pharmacists should ask about OTC analgesics and counsel patients in English and French to reduce accidental NSAID stacking and bleeding risk.

Cultural Perceptions & Patient Habits — Canadian Forums, Bilingual Needs, Urban Vs Rural

Patients often ask whether a long‑acting NSAID is worth taking when ibuprofen is available over the counter.

Online Canadian forums and patient groups commonly show preference for short‑acting OTC NSAIDs such as ibuprofen due to perceived safety and cost.

There is a general cautious attitude toward older long‑acting NSAIDs because of historical adverse-event reports.

Demand for clear bilingual information in English and French is high across Canada, and newcomer and Indigenous communities frequently request culturally concordant explanations.

Urban patients often have faster access to specialist care and laboratory follow-up.

Rural and remote patients may rely heavily on local pharmacists for prescribing support and monitoring, and supply disruptions can affect continuity of therapy.

Practical communication strategies that work in Canada include teach‑back, bilingual leaflets and engagement with community health representatives to support monitoring and adherence.

Availability & Pricing Patterns — Retail Chains, Online Pharmacies, Cross‑Border Notes

Where can a Canadian patient get Feldene or piroxicam?

Piroxicam is prescription-only in regulatory sources reviewed, and its presence in Canada depends on manufacturer submissions to Health Canada and DIN issuance.

Availability at national chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs varies with supplier distribution and DIN listings.

Online Canadian pharmacies dispense prescription medicines subject to provincial rules, and out‑of‑country imports require regulatory compliance.

Provincial drug plans may favour safer NSAIDs and may not list piroxicam for routine coverage—check ODB, PharmaCare and RAMQ for listing and special-authority requirements.

Cross-border purchases can appear cheaper in some cases, but Canadian patients should be mindful of regulatory differences, packaging and bilingual labelling.

• Where To Check Availability: Health Canada DIN database; provincial formulary lists; local wholesale distributors.
• How To Compare Prices: Compare retail pharmacy quotes, check provincial coverage, consider manufacturer patient-assistance programs; account for shipping and bilingual labelling needs when ordering from abroad.

In our online pharmacy, feldene is available without a prescription, with discreet delivery to Canada (English) in 5–14 days.

Telepharmacy and remote prescribing are increasingly used to address access gaps in rural communities.

Comparable Medicines And Preferences — Alternatives (DIN‑Based) With Pros & Cons

Clinicians and patients want to know what alternatives exist and why one might be chosen over another.

Common alternatives available in Canada include ibuprofen, diclofenac, meloxicam and naproxen.

Compared with piroxicam’s long half‑life of about 50 hours, these agents have differing half‑lives and COX selectivity that influence GI, cardiovascular and renal risk.

Topical NSAIDs are a useful alternative for localized osteoarthritis with lower systemic exposure and often fewer systemic risks.

Choose an agent based on comorbidities, monitoring capacity, formulary access and patient values, and document shared decision-making in the patient record.

FAQ Section — Common Canadian Patient Questions

• Is Feldene Available Over The Counter In Canada?

  No—piroxicam (Feldene) is prescription-only in regulatory sources reviewed; check Health Canada and provincial formularies for current listing and coverage.

• Can I Take Piroxicam With My Blood Thinner?

  Generally not without careful monitoring because NSAIDs increase bleeding risk; coordinate with your prescriber and anticoagulation clinic.

• Is Piroxicam Safer Than Ibuprofen For Arthritis?

  Not necessarily—piroxicam’s long half‑life can raise GI and cardiovascular risks; many clinicians favour shorter‑acting NSAIDs or alternatives for high‑risk patients.

• How Long Should I Expect To Take It?

  Use the lowest effective dose for the shortest period; chronic therapy should be reviewed every 2–3 months with labs and blood pressure checks.

• What If I Live In A Remote Community?

  Arrange local follow-up with your pharmacist or telehealth; ensure bilingual instructions and a plan for emergency access given bleeding and renal risks.

For specific coverage and listing details, consult your provincial formulary and the Health Canada DIN lookup prior to initiating therapy.

Guidelines For Proper Use — Pharmacist Advice, Provincial Tips, Storage & Monitoring

Patients often want a simple checklist they can follow at home.

Pharmacist Checklist:

• Confirm indication and DIN before dispensing.
• Review all prescription and OTC medicines for interactions including anticoagulants, SSRIs and ACE inhibitors.
• Assess GI, cardiovascular and renal risk and counsel in English and French as required.
• Document counselling in the pharmacy management record.

Recommend the lowest effective dose between 10 mg and 20 mg per day and plan follow-up labs for renal and liver function and blood pressure checks within 4–12 weeks of initiation.

Storage Instructions:

• Store at 25°C; excursions allowed between 15–30°C.
• Keep in original packaging away from moisture and direct sunlight.
• Do not freeze gel or cream formulations.

Monitoring Schedule (Data Highlights):

Half‑life ≈ 50 hours—this increases accumulation risk and supports conservative dosing and monitoring.

Consider PPI gastroprotection for patients at high GI risk and avoid use in pregnancy and after CABG.

When To Seek Urgent Care:

• Signs of GI bleeding (black tarry stools, vomiting blood).
• Severe abdominal pain, unexplained shortness of breath or chest pain.
• Marked reduction in urine output or sudden swelling.

Provincial Tips:

Check ODB, PharmaCare or RAMQ for coverage rules and special‑authority processes and involve community pharmacists and health teams in rural and Indigenous settings for culturally safe monitoring.

Delivery Across Canada (English)